CO-INVEST WITH THE VISCOGLIOSI BROTHERS


Register with the Viscogliosi Brothers Co-Investor Network (VBIN) to view and participate in healthcare investment opportunities curated by Viscogliosi Brothers, LLC (VB)—a 22 year veteran investor in the $188 billion neuromusculoskeletal (NMS) sector.


Image 1


$1.1B+

Total Capital
Raised

$150M

Invested
Equity

18

Company
Exits

30+

Invested
Companies

$2.5B+

Transaction
Proceeds

3.5x


Average MOIC

How do you co-invest with the Viscogliosi Brothers?

Experience a new approach to investing by accessing healthcare investment opportunities in which Viscogliosi Brothers will also invest. Here is how those co-investment opportunities work:

picture 1
Deal Screening

VB reviews and selects
its opportunities from
hundreds presented annually.

picture 2
Deal Terms

VB negotiates and prepares
deal terms for presentation to
members.

picture 3
Funding

VB invests capital and
invites members to
co-invest.

picture 4
Network

Portfolio companies strengthen
with post-investment support
as VBIN grows.

VBIN Investment Opportunities

Opportunities presented to the VBIN include those in which VB chooses to invest in as well as those presented by VB’s affiliate company, Viscogliosi & Company, LLC a registered broker-dealer and member of FINRA/SIPC. VB’s experienced investment team identifies and conducts rigorous research on hundreds of companies annually to tap into cutting-edge innovation in the healthcare space. Register to see the details behind all opportunities available to the VBIN.

Closed
Series A
Companion Spine, LLC

Companion Spine, LLC is an early commercial-stage medical device company addressing the clinical unmet need for interventional spine pain treatment technology and diagnostic devices for degenerative disc disease and lumbar spinal stenosis.

Closed
Series B Preferred Equity
Woven Orthopedic Technologies, LLC

Woven Orthopedic Technologies, LLC is an early commercial stage medical device company that helps surgeons overcome challenges experienced when performing surgery in compromised fixation scenarios through the use of its proprietary implementation system.

Closed
Series B
Spine Biopharma, LLC

Spine BioPharma is a late clinical-stage biopharmaceutical company that develops market innovative non-opiate, non-surgical therapies to treat degenerative spine related diseases.

VIEW MORE INVESTMENT OPPORTUNITIES
Image 1

We Are Business Builders

VB focuses on creating tangible solutions that develop into sustainable businesses. We invest in companies focused on addressing unmet needs, while saving the healthcare system money. Our focus goes beyond serving the population today; we strive to create a better healthcare environment for future generations.